Pin Oak Investment Advisors Inc Gilead Sciences, Inc. Transaction History

Pin Oak Investment Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $17,433 - $21,846	-301 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $6,473 - $7,073	-102 Reduced 25.31%	301 $21,000
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $24,832 - $27,315	403 New	403 $26,000
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $2,375 - $2,622	-38 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $2,351 - $2,636	38 New	38 $3,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Pin Oak Investment Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Pin Oak Investment Advisors Inc with notifications on news.